41
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Substituent Effect on Carbodithioate Ligand Field Strength in Iron(III) Carbodithioates: Synthesis and Characterization

, &
Pages 609-623 | Received 03 Jun 1998, Accepted 03 Nov 1999, Published online: 23 Apr 2008
 

Abstract

New iron(III) carbodithioate complexes of the general formulae Fe(Lcdt)3 [(where L is the anion of an heterocyclic amine and Lcdt are the following anions: 4-methylpiperazine-l-carbodithioate (4-MPipzcdt), 4-phenylpiperazine-l-carbodithioate (4-PPipzcdt), piperidinecarbodithioate (Pipdcdt), 2-methylpiperidine-carbodithioate (2-MPipdcdt), 4-methylpiperidine carbodithioate (4-MPipdcdt), morpholinecarbodithioate (Morphcdt), 2,6-dimethylmorpholinecarbodithioate (2,6-M2Morphcdt), 2,5-dimethylpyrrolecarbodithioate (2,5-M2Pyrrcdt)] and Fe2[2-MPipz(cdt)2]3 [(2-MPipz(cdt)2 = 2-methylpiperazine-l, 4-dicarbodithioate dianion)] have been synthesized. These compounds have been characterized by elemental analyses, infrared spectral and magnetic susceptibility measurements and in some cases by electron paramagnetic resonance studies. The room temperature magnetic moments of the complexes are indicative of a trigonally distorted octahedral geometry around iron(III) observing a 6A12T2 spin croosover phenomenon. The EPR studies give the gav values 4.4960-4.9962.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.